Literature DB >> 9431732

Factors associated with dropout in a group cognitive behaviour therapy for mood disorders.

T P Oei1, T Kazmierczak.   

Abstract

The high prevalence of premature attrition from psychotherapy is a phenomenon which has been well recognized in the psychological literature. The pressing concern that a number of clients may not be benefiting from treatment because they are dropping out has led to a plethora of research in the area of individual psychotherapy. No studies, however, have attempted to investigate the characteristics of dropout in group cognitive behaviour therapy for depression. To address this gap in research, the present study examined the factors associated with dropout in a group cognitive behaviour therapy for depression, using 131 Ss who went through the group therapy for 12 weeks. The results showed that sociodemographic measures (e.g. age) and measures of depressive symptoms (e.g. depression scores) did not discriminate dropouts from completers. An investigation of patterns of mood changes in the course of the therapy also failed to find significant differences between the dropouts and completers. However, weekly therapist rating of client participation revealed that dropouts participated significantly less than completers during the therapy sessions. The results are discussed in light of the findings of current literature and future research in premature attrition.

Entities:  

Mesh:

Year:  1997        PMID: 9431732     DOI: 10.1016/s0005-7967(97)00060-0

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  9 in total

1.  Factors associated with attrition from a randomized controlled trial of meaning-centered group psychotherapy for patients with advanced cancer.

Authors:  Allison J Applebaum; Wendy G Lichtenthal; Hayley A Pessin; Julia N Radomski; N Simay Gökbayrak; Aviva M Katz; Barry Rosenfeld; William Breitbart
Journal:  Psychooncology       Date:  2011-07-12       Impact factor: 3.894

Review 2.  The impact of informing psychiatric patients about their medication: a systematic review.

Authors:  Franciska A M Desplenter; Steven Simoens; Gert Laekeman
Journal:  Pharm World Sci       Date:  2007-01-10

3.  Predictors of treatment utilization in major depression.

Authors:  Dana M Alonzo; Jill M Harkavy-Friedman; Barbara Stanley; Ainsley Burke; J John Mann; Maria A Oquendo
Journal:  Arch Suicide Res       Date:  2011

4.  Improving Quality of Life for Patients with Major Depressive Disorder by Increasing Hope and Positive Expectations with Future Directed Therapy (FDT).

Authors:  Jennice S Vilhauer; Julissa Cortes; Nazanin Moali; Sally Chung; James Mirocha; Waguih William Ishak
Journal:  Innov Clin Neurosci       Date:  2013-03

5.  Treatment modality preferences and adherence to group treatment for panic disorder with agoraphobia.

Authors:  Michel Perreault; Dominic Julien; Noé Djawn White; Claude Bélanger; André Marchand; Theodora Katerelos; Diana Milton
Journal:  Psychiatr Q       Date:  2014-06

6.  Effectiveness of cognitive behavioral group therapy for depression in routine practice.

Authors:  Jens C Thimm; Liss Antonsen
Journal:  BMC Psychiatry       Date:  2014-10-21       Impact factor: 3.630

7.  Barriers to Mindfulness: a Path Analytic Model Exploring the Role of Rumination and Worry in Predicting Psychological and Physical Engagement in an Online Mindfulness-Based Intervention.

Authors:  Moitree Banerjee; Kate Cavanagh; Clara Strauss
Journal:  Mindfulness (N Y)       Date:  2017-11-06

8.  Effect of Life Satisfaction on Depression among Childless Married Couples: A Cross-Sectional Study.

Authors:  Ju-Young Ha; Hyo-Jin Park
Journal:  Int J Environ Res Public Health       Date:  2022-02-12       Impact factor: 3.390

9.  A pilot study evaluating a support programme for parents of young people with suicidal behaviour.

Authors:  Lorna Power; Sophia Morgan; Sinead Byrne; Carole Boylan; Andreé Carthy; Sinead Crowley; Carol Fitzpatrick; Suzanne Guerin
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2009-07-15       Impact factor: 3.033

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.